Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers

Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers

ObjectiveUnlike for patients with other forms of cardiomyopathies, those with severe ventricular dysfunction due to Duchenne muscular dystrophy (DMD) are not offered implantable cardioverter-defibrillator (ICD) therapy routinely. This prospective study aimed to determine the views of DMD-patients an...

Full description

Bibliographic Details
Main Authors:	John P Bourke, Ursula M Hiermeier, Christine Baker
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-06-01
Series:	Open Heart
Online Access:	https://openheart.bmj.com/content/7/1/e001230.full

Similar Items

Arrhythmias and cardiac MRI associations in patients with established cardiac dystrophinopathy
by: John Bourke, et al.
Published: (2024-04-01)

Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations
by: Ros Quinlivan, et al.
Published: (2022-11-01)

Cardiac rehabilitation in patients with pacemakers and implantable cardioverter defibrillators
by: Marie Christine Iliou, et al.
Published: (2016-10-01)

Efficacy and safety of hydrokinesitherapy in patients with dystrophinopathy
by: V. M. Suslov, et al.
Published: (2023-07-01)

MicroRNAs in Dystrophinopathy
by: Ahyoung Lee, et al.
Published: (2022-07-01)

The dystrophinopathies in Costa Rica
by: Jorge Azofeifa
Published: (2004-09-01)

Repeated misclassifications of tachycardia by an implantable cardiac defibrillator
by: Atsuyuki Watanabe, et al.
Published: (2020-01-01)

Advances in Dystrophinopathy Diagnosis and Therapy
by: Fawzy A. Saad, et al.
Published: (2023-08-01)

The Dystrophinopathies: An Alternative to the Structural Hypothesis
by: C.George Carlson
Published: (1998-07-01)

Magnetic resonance imaging in a patient with an implantable cardiac defibrillator
by: Hiroshi Furusho MD, et al.
Published: (2012-12-01)

Implantable cardioverter defibrillators in the prevention of sudden cardiac death
by: L A Bockeria, et al.
Published: (2017-12-01)

Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies
by: Kenji Rowel Q. Lim, et al.
Published: (2020-07-01)

Implantable Cardiac Defibrillator (ICD) receiver screening tool /
by: Norzahirah Mohd. Rodi, 1993-, author 637545, et al.
Published: (2015)

Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
by: Kenan Yalta, MD, et al.
Published: (2022-09-01)

Comprehensive genetic characteristics of dystrophinopathies in China
by: Peipei Ma, et al.
Published: (2018-07-01)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
by: Massimiliano Marini, et al.
Published: (2023-05-01)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
by: Abdulkadir Uslu, et al.
Published: (2019-03-01)

Psychological factors and cardiac repolarization instability during anger in implantable cardioverter defibrillator patients
by: David S. Krantz, et al.
Published: (2021-07-01)

Implantable Cardiac Defibrillators: Who Needs Them and Who Does Not?
by: C. Richard Conti
Published: (2016-01-01)

Pseudo loss of capture on 12 lead electrocardiogram in patient with an implantable cardiac defibrillator
by: Tuppence Richman, et al.
Published: (2023-05-01)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
by: Rakesh Malhotra, et al.
Published: (2017-11-01)

Primary Prevention Implantable Cardiac Defibrillators: A Townsville District Perspective
by: Nathan Engstrom, et al.
Published: (2020-10-01)

Genotypes and Phenotypes of DMD Small Mutations in Chinese Patients With Dystrophinopathies
by: Liang Wang, et al.
Published: (2019-02-01)

Age, Sex, and Remote Monitoring Differences in Device Acceptance for Patients With Implanted Cardioverter Defibrillators in Canada
by: Jessica Ng, MSc, et al.
Published: (2020-11-01)

Correction to: Comprehensive genetic characteristics of dystrophinopathies in China
by: Peipei Ma, et al.
Published: (2021-06-01)

Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan
by: Mariko Okubo, et al.
Published: (2017-08-01)

Validity and reliability of the Brazilian Portuguese version of the Florida Patient Acceptance Survey for patients with implantable cardioverter defibrillators
by: Katia Regina Silva, et al.
Published: (2023-12-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation
by: Judd Robert M, et al.
Published: (2011-02-01)

Patient Alerting Features in Implantable Defibrillators
by: Dirk Vollmann, et al.
Published: (2008-02-01)

Dystrophinopathies are characterised by impaired cardiac metabolism, contractile dysfunction and fibrosis in patients with and without coxsackie B3 exposure
by: Petersen Steffen, et al.
Published: (2011-02-01)

Implantable Cardioverter Defibrillator
by: Dicky Armen Hanafy
Published: (2013-07-01)

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator
by: Mariusz Klopotowski, et al.
Published: (2022-03-01)

Anxiety, depression and cardiac anxiety in patients with implantable cardioverter-defibrillator according to gender and age
by: Isabelle Brigliadori Ignácio, et al.
Published: (2021-02-01)

Implantable Cardiac Defibrillator (ICD) receiver screening tool [electronic resource] /
by: Norzahirah Mohd. Rodi, 1993- author 637545
Published: (2015)

The current status of cardiac resynchronization therapy and implantable cardioverter defibrillator in China
by: Xiaohan Fan, et al.
Published: (2016-01-01)

Physicians’ knowledge and attitudes in Saudi Arabia regarding implantable cardiac defibrillators
by: Tariq Alhogbani, et al.
Published: (2018-04-01)

Flatline on the alternate vector…Is this subcutaneous implantable cardiac defibrillator lead fractured?
by: Louisa O’Neill, MD, PhD, et al.
Published: (2021-11-01)

Needs management in families affected by childhood-onset dystrophinopathies
by: Kristin M Conway, et al.
Published: (2019-03-01)